Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (80455)	5/5/2000 5:20:00 PM
From: re3	Read Replies (1) \| Respond to of 132070

pizza ? i thought you were dieting...<g>

To: Knighty Tin who wrote (80455)	5/5/2000 8:53:00 PM
From: Skeeter Bug	Respond to of 132070

dude, call a 4th third what it really is! ;-)

To: Knighty Tin who wrote (80455)	9/28/2000 9:53:02 PM
From: tom rusnak	Read Replies (1) \| Respond to of 132070

RE: biotech/FDA/SNUS G'day Michael, This is really a general question about biotech companies and FDA approvals but in the interest of self interest I'll formulate it regarding SNUS (Sonus Pharmaceuticals). SNUS was expecting FDA approval in March and looking at the chart from January at 2ish it was straight uphill to 9+ around approval time. They got knocked back for some labelling issues and drifted back to the 02 area code. They are expecting more news from FDA on OCT 28th. First of all, do the majority of stocks awaiting FDA approval news head for the heavens going into the news? Secondly, do you know much about SNUS in particular? Thanks as always, tom